Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis I: Introduction01:22

Pericarditis I: Introduction

432
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
432
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

369
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
369
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

382
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
382
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

344
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
344

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond neutrality: reassessing diabetes as a modulator in stress cardiomyopathy.

Postgraduate medicine·2025
Same author

Editorial: Simultaneous extracorporeal membrane oxygenation and Impella: Synergy or contrariety?

Cardiovascular revascularization medicine : including molecular interventions·2024
Same author

A Case Of Takotsubo Syndrome Precipitated By Diabetic Ketoacidosis.

Journal of Ayub Medical College, Abbottabad : JAMC·2024
Same author

Diabetes Mellitus as a Protective Factor in Takotsubo Cardiomyopathy.

Anatolian journal of cardiology·2023
Same author

Stanford Type A Aortic Dissection in A Patient with Primary Antiphospholipid Syndrome and Coronavirus Disease 2019.

Aorta (Stamford, Conn.)·2023
Same author

ST-elevation in Takotsubo cardiomyopathy.

Journal of electrocardiology·2023
Same journal

Incidence of Hepatitis C Virus and Other Bloodborne Virus Infections Among Nonurban Residents of Fairfield and New Haven Counties, Connecticut Who Inject Drugs.

Connecticut medicine·2021
Same journal

Remarks from the Annual Meeting.

Connecticut medicine·2018
Same journal

Address of the Outgoing President: Evolution.

Connecticut medicine·2018
Same journal

Address of the New President: One Society.

Connecticut medicine·2018
Same journal

Post Integration Trauma Syndrome (PITS).

Connecticut medicine·2018
Same journal

New Federal Drug Administration Fluoroquinolone Warning and a Practical Approach to Managing Patients.

Connecticut medicine·2018
See all related articles

Related Experiment Video

Updated: Feb 10, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.1K

Colchicine In Epistenocardiac Pericarditis.

Lovely Chhabra, N Gurukripa Kowlgi, David H Spodick

    Connecticut Medicine
    |May 18, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Epistenocardiac pericarditis (EP), a rare post-myocardial infarction (MI) complication, presents treatment challenges. This case series explores colchicine as an alternative therapy for EP when high-dose aspirin is not feasible.

    More Related Videos

    Studying Mitotic Checkpoint by Illustrating Dynamic Kinetochore Protein Behavior and Chromosome Motion in Living Drosophila Syncytial Embryos
    13:59

    Studying Mitotic Checkpoint by Illustrating Dynamic Kinetochore Protein Behavior and Chromosome Motion in Living Drosophila Syncytial Embryos

    Published on: June 14, 2012

    11.9K
    Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
    07:20

    Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium

    Published on: April 9, 2019

    9.8K

    Related Experiment Videos

    Last Updated: Feb 10, 2026

    Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
    08:56

    Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

    Published on: September 24, 2021

    3.1K
    Studying Mitotic Checkpoint by Illustrating Dynamic Kinetochore Protein Behavior and Chromosome Motion in Living Drosophila Syncytial Embryos
    13:59

    Studying Mitotic Checkpoint by Illustrating Dynamic Kinetochore Protein Behavior and Chromosome Motion in Living Drosophila Syncytial Embryos

    Published on: June 14, 2012

    11.9K
    Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
    07:20

    Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium

    Published on: April 9, 2019

    9.8K

    Area of Science:

    • Cardiology
    • Internal Medicine
    • Clinical Research

    Background:

    • Epistenocardiac pericarditis (EP) is a rare complication occurring early after myocardial infarction (MI).
    • Standard treatment involves high-dose aspirin, but this can be contraindicated with newer antiplatelet agents.
    • The efficacy of colchicine for EP is not well-established, necessitating further investigation.

    Purpose of the Study:

    • To evaluate the efficacy and safety of colchicine in treating epistenocardiac pericarditis (EP).
    • To present a case series of patients with EP treated with colchicine.

    Main Methods:

    • A case series of 11 patients diagnosed with epistenocardiac pericarditis (EP) was retrospectively analyzed.
    • Patients received colchicine for treatment of EP.
    • Clinical outcomes and adverse events were documented.

    Main Results:

    • Colchicine treatment was associated with symptom resolution in the studied EP patients.
    • No major adverse events were reported during colchicine therapy for EP.
    • Further studies are needed to confirm these preliminary findings.

    Conclusions:

    • Colchicine may be a viable alternative treatment for epistenocardiac pericarditis (EP), especially when high-dose aspirin is contraindicated.
    • This case series suggests colchicine is safe and potentially effective for managing EP.
    • Larger, prospective studies are warranted to establish definitive evidence for colchicine in EP treatment.